Xianquan Zhan

Shandong First Medical University

Xianquan Zhan received his MD and Ph.D. in Preventive Medicine at West China University of Medical Sciences. He received his post-doctoral training in oncology and cancer proteomics at Central South University, China, and University of Tennessee Health Science Center (UTHSC), USA. He worked at UTHSC and the Cleveland Clinic in 2001–2012 and achieved the rank of associate professor at UTHSC. Currently, he is a full professor at Central South University and Shandong First Medical University, both in China, and an advisor to MS/PhD students and postdoctoral fellows. He is also a fellow of the Royal Society of Medicine and European Association for Predictive Preventive Personalized Medicine (EPMA), a national representative of EPMA, and a member of the American Society of Clinical Oncology (ASCO) and the American Association for the Advancement of Sciences (AAAS). He is also editor in chief of the International Journal of Chronic Diseases & Therapy, an associate editor of EPMA Journal, Frontiers in Endocrinology, and BMC Medical Genomics, and a guest editor of Mass Spectrometry Reviews, Frontiers in Endocrinology, EPMA Journal, and Oxidative Medicine and Cellular Longevity. He has published more than 170 articles, 29 book chapters, 8 books, and 3 international patents in the field of clinical proteomics and biomarkers.

Xianquan Zhan

5books edited

11chapters authored

Latest work with IntechOpen by Xianquan Zhan

Modifications in biomacromolecules (DNA, RNA, and proteins) are important molecular events in different pathophysiological conditions. These modifications include DNA modifications, RNA post-transcriptional modifications, and protein post-translational modifications that regulate the structures and functions of biomacromolecules and even the entire biological system. In addition, they are associated with a wide spectrum of diseases. Biomacromolecular modifications are important factors in creating proteoforms that constitute the end-point structural and functional forms of a gene or protein that can be applied for predictive, preventive, and personalized medicine (PPPM) as well as precision medicine (PM).

Go to the book